IgA肾病的中西医诊治进展  

Progress on Traditional Chinese and Western Medicine in the Diagnosis and Treatment of IgA Nephropathy

在线阅读下载全文

作  者:王银萍[1] 陈静[2] WANG Yinping;CHEN Jing(Department of Nephrology,Affiliated Hospital of Changchun University of Chinese Medicine,Jilin Province,Changchun 130021,China;Department of Orthopedics,Changchun Hospital of Traditional Chinese Medicine,Jilin Province,Changchun 130022,China)

机构地区:[1]长春中医药大学附属医院肾内科,吉林长春130021 [2]长春市中医院骨科,吉林长春130022

出  处:《中国中医药现代远程教育》2024年第3期148-150,共3页Chinese Medicine Modern Distance Education of China

基  金:吉林省教育厅“十三五”科学技术项目[No.JJKH20190465KJ]。

摘  要:IgA肾病是一种原发性肾小球肾炎,容易引起肾损害,最终导致终末期肾病,使患者进入肾替代治疗阶段,给患者及其家庭带来严重的心理及经济负担。针对IgA肾病,西医逐渐研制各种靶向药物但疗效及不良反应仍需观察。文献、临床实践表明,中医药治疗IgA肾病可有效减少尿蛋白及尿红细胞,有效延缓肾功能减退,且无毒副作用。现收集大量文献,从中医对IgA肾病的病因病机认识及西医对IgA肾病的发病机制研究和治疗进行总结,让更多的青年医师借鉴学习,为更多的IgA肾病患者带来福音。IgA nephropathy is a kind of primary glomerulonephritis,which is easy to cause kidney damage and eventually lead to end-stage renal disease,so that patients enter the renal replacement therapy stage,and bring serious psychological and economic burden to patients and their families.For IgA nephropathy,Western medicine has gradually developed a variety of targeted drugs,but the effi-cacy and adverse reactions still need to be observed.Literature and clinical practice have shown that traditional Chinese medicine can effectively reduce urinary protein and urinary red blood cells in IgA nephropathy,effectively delay renal function decline,and have no toxic side effects.Now,a large number of literatures were collected to summarize the etiology and pathogenesis of IgA nephropathy in traditional Chinese medicine and the pathogenesis and treatment of IgA nephropathy in Western medicine,so that more young doctors can learn from and bring good news to more IgA nephropathy patients.

关 键 词:尿血 IGA肾病 中医病因病机 西医发病机制 综述 

分 类 号:R692.31[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象